← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Metabolic Solutions Development Co
Kalamazoo, MI
$2,820,156
Total funding
4
Grants
Funding over time
peak $1.2M · FY2009–14$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$2,820,156 · 4
By mechanism
R42$2,557,289 · 2
R41$140,911 · 1
R43$121,956 · 1
Investigators at Metabolic Solutions Development Co
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
PPAR-sparing/free Thiazolidinediones for Treatment of Diabetes$634,311
R42 · FY2011 · DK
PPAR-sparing/free Thiazolidinediones for Treatment of Diabetes$608,312
R42 · FY2010 · DK
Evaluation of PPARgam-sparing TZDs for Treating Non-Alcoholic Fatty Liver Disease$563,804
R42 · FY2011 · AA
Evaluation of PPARgam-sparing TZDs for Treating Non-Alcoholic Fatty Liver Disease$560,998
R42 · FY2012 · AA
Evaluation of PPARgam-sparing TZDs for Treating Non-Alcoholic Fatty Liver Disease$140,911
R41 · FY2009 · DK
PPAR-sparing/free Thiazolidinediones for Treatment of Diabetes$139,864
R42 · FY2009 · DK
Therapeutic Use of mTOT Modulators in Polycystic Kidney Disease$121,956
R43 · FY2014 · DK
Evaluation of PPARgam-sparing TZDs for Treating Non-Alcoholic Fatty Liver Disease$50,000
R42 · FY2012 · AA